Conversation

Notices

1. Ars Technica (arstechnica@mastodon.social)'s status on Friday, 04-Oct-2024 02:38:16 JST Ars Technica

   Popular gut probiotic completely craps out in randomized controlled trial

   If you're familiar with the history of Activia, you may not be surprised.

   https://arstechnica.com/health/2024/10/popular-gut-probiotic-completely-craps-out-in-randomized-controlled-trial/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social

   • Stuhl, Stühler, am Stühlsten (stueja@mastodon.social)'s status on Friday, 04-Oct-2024 02:50:24 JST Stuhl, Stühler, am Stühlsten

     in reply to

     @arstechnica best headline this week 🤗🎉

   • Chancerubbage (chancerubbage@mastodon.social)'s status on Friday, 04-Oct-2024 03:07:36 JST Chancerubbage

     in reply to

     @arstechnica FWIW, I’ve never eaten or taken probiotics with hopes of restoring regularity as much as possibly avoiding inflammation.

   • KB Sez (kbsez@mastodon.social)'s status on Friday, 04-Oct-2024 03:10:43 JST KB Sez

     in reply to

     @arstechnica

     This is why people who know what they are talking about are all in on Prebiotics.

   • Joe Sears (eclecticdad@mastodon.social)'s status on Friday, 04-Oct-2024 03:45:55 JST Joe Sears

     in reply to

     @arstechnica no shit!